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Abstract
Introduction: Aggregatibacter aphrophilus (formerly Haemophilus aphrophilus and H. paraphrophilus) is classically
associated with infective endocarditis. Other infections reported in the literature include brain abscess, bone and
joint infections and endophthalmitis. There are only two cases of empyema ever reported due to this organism.
We report the isolation of A. aphrophilus from pleural fluid on three separate hospital admissions in a patient with
recurrent empyema.
Case presentation: A 65-year-old female patient of Caucasian origin presented with a three-week history of fever,
shortness of breath and dry cough. She was found to have a pleural empyema so a chest drain was inserted and a
sample of pus was sent to the microbiology laboratory. After overnight incubation, a chocolate blood agar plate
incubated in 5% carbon dioxide showed a profuse growth of small, round, glistening colonies which were
identified as Gram-negative coccobacilli. They were oxidase- and catalase-negative. Biochemical testing using RapID
NH confirmed the identity of the organism as A. aphrophilus. It was susceptible to amoxicillin, levofloxacin and
doxycycline. Our patient was treated with intravenous amoxicillin with clavulanic acid and clarithromycin followed
by oral doxycycline, but was re-admitted twice over the next three months with recurrent empyema and the same
organism was isolated. Each episode was managed with chest drainage and a six-week course of antibiotic–
doxycycline for the second episode and amoxicillin for the third episode, after which she has remained well.
Conclusion: This is the first case report of recurrent empyema due to A. aphrophilus. Our patient had no
underlying condition to explain the recurrence. Although our isolate was doxycycline susceptible, our patient had
recurrent infection after treatment with this antibiotic, suggesting that this antibiotic is ineffective in treatment of
deep-seated A. aphrophilus infection. This organism can be difficult to identify in the laboratory because, unlike
closely related Haemophilus spp., it is oxidase-negative, catalase-negative and X and V independent.
Introduction
Aggregatibacter aphrophilus (formerly Haemophilus aph-
rophilus and H. paraphrophilus)i sp a r to ft h en o r m a l
oropharyngeal flora. It is a Gram-negative coccobacillus
that requires 5% carbon dioxide (CO2) for primary isola-
tion, growing best on chocolate blood agar. It can be
difficult to identify in the laboratory because, unlike clo-
sely related Haemophilus spp., it is oxidase-negative, cat-
alase-negative and X and V independent. It was first
described by Khairat in 1940 when it was isolated from
a patient with infective endocarditis [1]. He chose the
species name to reflect the requirement for CO2
(literally ‘froth-loving’). Other infections reported in the
literature include brain abscess, bone and joint infec-
tions and endophthalmitis [2]. Empyema was first
described in 1965 in a patient who responded to a com-
bination of penicillin and tetracycline [3]. A second case
in more recent times was treated with amoxicillin with
clavulanic acid [2]. Antibiotic therapy with amoxicillin
+/- beta-lactamase inhibitor, third generation cephalos-
porins or fluoroquinolones have all been used success-
fully to treat A. aphrophilus infections [2]. However,
resistance to cephalosporins has been described [4]. We
report for the first time the isolation of A. aphrophilus
from pleural fluid on three separate hospital admissions
in a patient with recurrent empyema. * Correspondence: lratnayake@nhs.net
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A 65-year-old female patient of Caucasian origin was
admitted to our hospital with a three-week history of
fever, shortness of breath and dry cough. She did not
complain of hemoptysis or loss of weight, she was not a
smoker and she had no history of underlying lung disor-
ders. On examination her temperature was 37.9°C. Her
respiratory rate was 20 breaths per minute with an oxy-
gen saturation of 88% on air. An examination of her
respiratory system revealed decreased breath sounds and
dullness to percussion in the base of her right lung.
Examination of her cardiovascular system, abdomen and
central nervous system were normal. Investigations
showed a white cell count of 28.2 × 10
9/L (normal
range 4-11 × 10
9/L) with neutrophilia, and her C-reac-
tive protein level was 429 mg/L (normal range up to 5
mg/L).
A chest X-ray on admission showed opacification of
her right middle and lower zone and moderate right-
sided pleural effusion (Additional file 1 and Figure 1).
She was started on intravenous amoxicillin with clavula-
nic acid and clarithromycin as per hospital protocol for
severe community-acquired pneumonia. A wide bore
chest drain was inserted and a sample of pus was inocu-
lated into aerobic and anaerobic blood culture bottles.
On day two of incubation in the BacT/ALERT auto-
mated blood culture system (bioMérieux, Basingstoke,
UK) both bottles signaled positive but no organisms
were seen on Gram stain. After overnight incubation at
37°C there was poor growth on blood agar, but the cho-
colate blood agar plate incubated in 5% CO2 showed a
profuse growth of small, round, glistening colonies
(Additional file 1 and Figure 2) which were identified as
Gram-negative coccobacilli. Biochemical panel testing
on our isolate using API NH (bioMérieux, Basingstoke,
UK) was inconclusive but A. aphrophilus was suspected
because it was oxidase-negative, catalase-negative and ×
and V factor independent. Identification of our isolate
was confirmed by the reference laboratory using RapID
NH (Oxoid, Basingstoke, UK). Our patient responded to
intravenous amoxicillin with clavulanic acid and clari-
thromycin followed by oral doxycycline (two weeks total
antibiotic course). However she was readmitted twice
over the next three months with recurrent empyema
and the same organism was isolated. Each episode was
managed with chest drainage and a six-week course of
antibiotics; doxycycline for the second episode and
amoxicillin for the third, after which she has remained
well.
Discussion
A. aphrophilus is the species which now includes both V
factor independent (formerly H. aphrophilus) and V fac-
tor dependent (formerly H. paraphrophilus)s t r a i n s .
Both are × factor independent, although the former
requires hemin-containing media on primary isolation.
It is oxidase-negative and catalase-negative, in contrast
t ot h em o r ec o m m o n l y - i s o l a t e dH. influenzae and H.
parainfluenzae, which are both oxidase- and catalase-
positive. Because of this, diagnostic laboratories may
have difficulty in identifying A. aphrophilus. Indeed,
there are reports of this organism being misidentified as
Pasteurella spp. [5,6].
Figure 1 Chest X-ray on admission.T h i sX - r a yi m a g es h o w sa
large right-sided pleural effusion.
Figure 2 Growth on chocolate agar. This shows a profuse growth
of small, round, glistening colonies.
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of A. aphrophilus, which is more commonly associated
with infective endocarditis. Our patient was investigated
for possible underlying causes of recurrent empyema.
Factors predisposing to aspiration, such as altered men-
tal status, alcoholism and periodontal disease have been
linked to the development of empyema. However none
of these were applicable to our patient. There was no
evidence of infective endocarditis, malignancy, lung
abscess, subdiaphragmatic infection or esophageal leak
and no history of thoracic trauma or surgery. Her
immunoglobulin levels were normal. Despite two
courses of doxycycline our patient’s empyema recurred,
but it was successfully treated with amoxicillin on the
third episode. Despite the organism’s susceptibility to
doxycycline, our experience suggests that this antibiotic
is ineffective in treatment of deep-seated A. aphrophilus
infections. Although the 1965 case report patient was
successfully treated with tetracycline, it was in combina-
tion with high-dose penicillin. In more recent times
amoxicillin +/- beta-lactamase inhibitor, third-genera-
tion cephalosporins and fluoroquinolones have all been
used to successfully treat these infections [2].
Unfortunately there are no conclusive studies on dura-
tion of antibiotic therapy for most bacterial pleural
space infections. The British Thoracic Society has pub-
lished guidelines on managing pleural infections and
recommends three weeks of antibiotic therapy [7]. The
treatment of the first episode of infection in our patient
could therefore be considered inadequate as she only
had two weeks of antibiotics.
Conclusion
To the best of our knowledge, this is the first case
report of recurrent empyema due to A. aphrophilus.
Our patient had no underlying condition to explain
recurrent empyema. Although our isolate was doxycy-
cline susceptible, our patient had recurrent infection
after treatment with this antibiotic, suggesting that this
antibiotic is ineffective in treatment of deep-seated A.
aphrophilus infection. This organism can be difficult to
identify in the laboratory because, unlike closely related
Haemophilus spp., it is oxidase-negative, catalase-nega-
tive and X and V independent.
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Written informed consent was obtained from the patient
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